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MARC Project 5:
MOLECULAR EPIDEMIOLOGY OF ALCOHOLISM AND
COMORBID DISORDERS

Michael T. Lynskey, PhD
Department of Psychiatry
Washington University School of Medicine

ABSTRACT


The MARC research project 5 builds upon gene-discovery
projects such as COGA (Collaborative Study on the Genetics
of Alcoholism: PIs Begleiter and Reich), and similar projects
which are studying treatment-ascertained alcoholics and their
relatives, and the MARC-affiliated Alcohol-QTL IRPG
consortium (PIs Heath, Martin, Madden), which is studying
community-ascertained alcoholics and heavy smokers and
their adult relatives, by incorporating a molecular genetic
component into 4 mature, prospective longitudinal studies
(PIs Chassin, Cooper, Heath, Sher) spanning the age-range
from early adolescence into young adulthood, with 3-7 waves
of prospective assessment.

ABSTRACT


(continued)

In addition to collecting DNA from the target samples, this
research project combines secondary data-analysis and
genotyping, proceeding in 4 stages:
• (i) longitudinal and other phenotypic analyses to establish
consistent phenotype definition across informative data-sets
(not all data-sets will be informative for all phenotypes of
interest);
• (ii) behavioral genetic analyses on existing twin data sets
(MOAFTS, and other U.S. and Australian data-sets to which
we have access through the MARC) to confirm heritability of
phenotypes defined at stage (i), and where possible
determine whether that phenotypic operationalization is
optimal for understanding genetic effects (which may not be
the case if the structures of genetic and environmental
influences are very different);
• (iii) genotyping for a limited number of candidate genes; and
• (iv) genetic association analysis.

ABSTRACT




(continued)

This carefully staged approach is necessary to minimize the
dangers of multiple testing when combining candidate gene
data and rich longitudinal data sets. For the same reason, we
focus on a limited number of candidate phenotypes where
prospective data are expected to be informative for
understanding the etiology of alcoholism.
Selection of candidate phenotypes and candidate genes is
guided by the MARC focus on the roles of overlapping
mechanisms of behavioral under control, negative affect
regulation and pharmacologic vulnerability in the etiology of
alcohol use disorders (AUDs), emphasizing AUD phenotypes
associated with (a) externalizing symptoms, (b) tolerance and
quantitative consumption indices, (c) cognitive aspects of
alcohol use (expectancies), (d) co-occurrence with tobacco
dependence, and (e) negative affect (depression, suicidality).

Specific Aims


Project Goals
• 1.1. To obtain blood samples for DNA extraction from 1,000
additional participants in the Heath longitudinal study of
female twins, adding to those collected from 4 prospective
longitudinal studies (Chassin, Cooper, Heath, Sher).
• 1.2. To Combine data from 5 longitudinal studies (Anokhin,
Bucholz, Chassin, Heath, Sher) to derive phenotypes of
alcohol involvement (use & problems), co-occurring features
based on longitudinal course, operationalized across two or
more data-sets and focused on 4 domains: (i) externalizing
symptoms; (ii) consumption, as well as cognitive aspects of
alcohol use (expectancies); and co-occurrence with (iii)
tobacco dependence and (iv) early trauma and depression.
Two approaches will be emphasized– developmental (e.g.
using mixture modeling to identify trajectories through time);
and state/trait modeling (e.g. modeling chronicity of effects).

Specific Aims


Project Goals (continued)
• 1.3 To test for candidate gene effects in all 5 samples on these
phenotypes (choice of candidate gene will be revised in the light
of emerging findings from ongoing gene-discovery efforts,
including MARC-affiliated projects, by the time the next
genotyping phase of the project begins):
 (i) AUDs and externalizing symptoms (DRD4, DRD5, SLC6A3
(DAT1 in old notation), GABRA2, GABRG2, CHRM2);
 (ii) AUDs and alcohol consumption (ALDH2 promoter
polymorphism, ADH1B (ADH2 in old notation), ADH1C (ADH3
in old notation), ADH4, ADH7, NTSR1);
 (iii) AUDs and tobacco consumption (CHRNA4,
CHRNA5/CHRNA3/CHRNB4, CHRNA7, CHRNB2, CHRNB3);
 (iv) AUDs and negative affect and stress-regulation, CRF,
NPY, SLC6A4 (5HTT in old notation), OPRM1). Many of these
polymorphisms are not adaptable to DNA array analysis and
require individual genotyping.

Specific Aims


Project Goals (continued)
• 1.4. For samples with adequate DNA yields, to expand
candidate gene analyses to a custom DNA array using the
top 1,000 associated single nucleotide polymorphisms
(SNPs) and flanking markers (about 20,000 SNPs total)
which replicate across ongoing genome wide association
studies of alcoholism in the Collaborative study on the
Genetics of Alcoholism (COGA) and Interactive Research
Project Grant (IRPG) studies.
• 1.5. To test if the most significant markers from GWA
studies of AUD are also associated with the longitudinal
phenotypes in 1.2 .

Preliminary Results




Efforts have been devoted to the organization of d data sets
and analytic approaches for the determination of phenotypes
of interests for genetic analysis and the completion of an
initial screening project to determine interest of subjects
participating in this project. Current progress for this study
has occurred on two fronts.
First, regular meetings of key investigators and
biostatisticians have been held over the last year to discuss
analytic approaches to the development of phenotypes
across data sets and to begin joining data sets. The
consensus is that phenotypes will be initially developed in
the two University of Missouri data sets then tested for
heritability in the MOAFTS (Missouri Adolescent Female Twin
Study) data set. Common items and constructs are being
developed.

Preliminary Results


(continued)

Second, a test of how to approach subjects for blood
collection was conducted in the Sher study: 257 individuals
(~½ of the target sample) was contacted to assess interest in
the study; 249 agreed to participate (a 96.9% initial
cooperation rate). Materials for blood collection were mailed
to potential participants. The participants are asked to go to
local clinics or laboratories for blood drawing and samples
are then express shipped to the laboratory at Washington
University. The next wave of interviews with the MOAFTS
sample has begun, and blood collection efforts with
cooperative twins is being conducted with these.

Preliminary Results (continued)


Progress to Date on Sample Collection and Genotyping
• Blood and buccal swab samples are now being collected
for DNA isolation from all four prospective studies
populations.
• To date ~3,300 specimens have been received in the lab:
Chassin (N = 583), Heath (N=1,504), Sher (N = 255),
Bucholz (N=416), Anokhin (N = 552).
• DNA has been prepared and under gone quality control
checks for 2,300 individuals. Functional repeat
polymorphism genotypes have been produced for DRD4,
and SLC6A4 (HHT) loci on 1318 samples, and for DRD5 ,
and SLC6A3 (DAT1) on 1,594 samples

Preliminary Results (continued)

 Immediate Plans

• During the next year we anticipate completing
sample collection, repeat polymorphism
genotyping and most single nucleotide
polymorphism (snp) genotyping as well as
developing phenotypes for joint samples.

